Oncology and Hematology
Episodes 1-16 of 75
- CME/CE Meeting
Optimizing the Treatment Continuum With a Molecular-Based Approach in HER2+ GI Cancers
June 28, 2024
13:15 - 14:15 CEST
Josep Tabernero, MD, PhD
Sara Lonardi, MD
Zev A. Wainberg, MD
- CME/CE
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
0.50 creditsJavier Cortes, MD, PhD
Komal Jhaveri, MD, FACP
Jeffrey V. Matous, MD
Donna Catamero, NP
Ajai Chari, MD
Nadia Harbeck, MD, PhD
Egbert Smit, MD
Susana Campos, MD, MPH
- MinuteCE®
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
1.00 program creditNadia Harbeck, MD, PhD
Egbert Smit, MD
Nadia Harbeck, MD, PhD
- MinuteCE®
Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials
1.00 program creditEgbert Smit, MD
Nadia Harbeck, MD, PhD
Egbert Smit, MD
Egbert Smit, MD
Susana Campos, MD, MPH
Susana Campos, MD, MPH
- Prev
- Next